GCN2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-12274
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Chicken
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for GCN2 Antibody
Immunogen
Synthetic peptide taken within amino acid region 1600-1700 on human GCN2 protein
Clonality
Polyclonal
Host
Chicken
Scientific Data Images for GCN2 Antibody
Western Blot: GCN2 Antibody [NBP3-12274]
Western Blot: GCN2 Antibody [NBP3-12274] - Kidney extract. Antibody diluiton 1:500 in DiluObuffer. Apparent MW is 240 KDa.Applications for GCN2 Antibody
Application
Recommended Usage
ELISA
1:10000
Immunocytochemistry/ Immunofluorescence
1:100
Immunohistochemistry
1:100
Immunoprecipitation
1:200
Western Blot
1:500
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
Contains Tris, HCl/glycine buffer (pH 7.4-7.8), 30% glycerol, 0.5% BSA, along with cryo-protective agents, and HEPES (exact storage and stabilization buffer information is proprietary).
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Store at -20C long term. Avoid freeze-thaw cycles.
Background: GCN2
Long Name
General Control Nonrepressed 2-like Protein
Alternate Names
EIF2AK4
Gene Symbol
EIF2AK4
Additional GCN2 Products
Product Specific Notices for GCN2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...